Dear Shareholders, On behalf of the board ("Board") of directors ("Directors") of Austar Lifesciences Limited ("Company"), I am pleased to present the annual report of the Company and its subsidiaries (collectively as the "Group" or "AUSTAR") for the year ended 31 December 2020 ("Year"). The year 2020 has been a challenging year for any individual, company and organization under the impact of the COVID-19 pandemic and its consequential policies. From a global perspective, the pandemic has not been slowing down even though China's pandemic conditions had become far stable and under extraordinary control. Under such conditions, the Group has been reacting, responding and acting during such extraordinary moments. Our colleagues could never have believed they were able to deliver our critical utilities and bioprocess systems to our COVID-19 vaccine manufacturer clients within 3 months from order to completion of installation and commissioning with construction sites working 24 hours a day non-stop together with our clients. With such fighting spirit and commitment to delivering vaccines more promptly to save more lives, through collaborations with our clients, new COVID-19 vaccine manufacturing facilities were completed with miraculous speed to produce vaccines delivered to various part of the world for clinical tests and usage applications. I am proud of what our colleagues have been contributing to society and people's heath at such difficult times when at the same time they still had to protect themselves from the virus infection at the working sites and travel routes.